008 |
|
090604s2009 ne o 000 0 eng d |
019 |
|
|a299710927
|
020 |
|
|a9780444531698
|
020 |
|
|a0444531696
|
035 |
|
|a(OCoLC)370435605|z(OCoLC)299710927
|
037 |
|
|a140964:141106|bElsevier Science & Technology|nhttp://www.sciencedirect.com
|
040 |
|
|aOPELS|beng|cOPELS|dBTCTA|dYDXCP
|
049 |
|
|aTEFA
|
050 |
14
|
|aRC600|b.A58 2009
|
082 |
04
|
|a616.978|222
|
245 |
00
|
|aAntiphospholipid syndrome in systemic autoimmune diseases:|h[electronic resource] /|ceditors, R. Cervera, Munther A. Khamashta, Joan Carles Reverter.
|
260 |
|
|aAmsterdam ;|aLondon :|bElsevier Science,|c2009.
|
300 |
|
|ap.|ccm.
|
490 |
1
|
|aHandbook of systemic autoimmune diseases ;|v10
|
505 |
0
|
|aClassification and Epidemiology of the Antiphospholipid Syndrome -- Laboratory Heterogeneity of the Antiphospholipid Antibodies -- Pathogenesis of the Antiphospholipid Syndrome -- Immunogenetics of the Antiphospholipid Syndrome -- Systemic Manifestations of the Antiphospholipid Syndrome -- Obstetric Manifestations of the Antiphospholipid Syndrome -- Antiphospholipid Antibodies and Infections and Drugs -- Antiphospholipid Antibodies and Malignancies -- Antiphospholipid Antibodies and Vascular Disorders (Atheromatosis and Vasculitis) -- Treatment of the Antiphospholipid Syndrome -- Difficult situations in the Antiphospholipid Syndrome.
|
520 |
|
|aAntiphospholipid syndrome is an autoimmune disease which causes abnormal blood clots. It is now recognised as a major cause of common conditions, including stroke, heart attack, miscarriage, epilepsy and memory loss and as such is gaining recognition in all branches of medicine, from obstetrics to cardiology, from psychiatry to orthopaedics.
This book provides an overview of our current understanding of this major disease. It includes the latest information on the new pathogenetic mechanisms involved as well as clinical manifestations in both b3 sthe thrombotic b4 s and b3 snon thrombotic b4 s manifestations of this important disease. * Comprehensive review of this major disease * Includes information on treatment options available.
|
533 |
|
|aElectronic reproduction.|bAmsterdam :|cElsevier Science & Technology,|d2009.|nMode of access: World Wide Web.|nSystem requirements: Web browser.|nTitle from title screen (viewed on June 3, 2009).|nAccess may be restricted to users at subscribing institutions.
|
650 |
0
|
|aAntiphospholipid syndrome.
|
655 |
7
|
|aElectronic books.|2local
|
700 |
1
|
|aCervera, Ricard.
|
700 |
1
|
|aKhamashta, Munther A.
|
700 |
1
|
|aReverter, Joan Carles.
|
710 |
2
|
|aScienceDirect (Online service)
|
776 |
1
|
|cOriginal|z9780444531698|z0444531696|w(OCoLC)318672002
|
830 |
0
|
|aHandbook of systemic autoimmune diseases ;|v10.
|
856 |
40
|
|3ScienceDirect|uhttp://www.sciencedirect.com/science/book/9780444531698|zAn electronic book accessible through the World Wide Web; click for information
|
938 |
|
|aBaker and Taylor|bBTCP|nBK0008169375
|
938 |
|
|aYBP Library Services|bYANK|n2959619
|
994 |
|
|aC0|bTEF
|